| PAR-21-271 | Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) | NIH | 8/17/2021 | 9/8/2024 |
| PAR-22-092 | Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) | NIH | 2/17/2022 | 9/8/2024 |
| PA-21-345 | Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) | NIH, CDC | 9/10/2021 | 9/10/2024 |
| PAR-22-064 | Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) | NIH | 11/16/2021 | 1/8/2025 |
| PAR-22-119 | Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) | NIH | 05/20/2022 | 02/20/2025 |
| PAR-22-105 | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | NIH | 5/15/2022 | 5/8/2025 |
| PAR-22-109 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | NIH | 5/16/2022 | 5/8/2025 |
| PAR-23-032 | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) | NIH | 12/5/2022 | 09/6/2025 |
| PAR-23-069 | HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) | NIH, NINDS, NEI, NIAMS, NCCIH, NCATS | 03/05/2023 | 09/06/2025 |
| PAR-22-106 | Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | NIH | 5/16/2022 | 9/8/2025 |
| NOT-OD-23-031 | Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars | ORWH, NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, NCCIH, NCI | 1/16/2023 | 10/1/2025 |
| NOT-OD-23-032 | Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards | ORWH, NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, NCCIH, NCI | 1/16/2023 | 10/1/2025 |
| PAR-23-025 | Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) | NIH | 3/6/2023 | 12/6/2025 |
| PAR-23-026 | Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) | NIH | 3/6/2023 | 12/6/2025 |
| NOT-AR-21-009 | NIAMS Policy for Acceptance of Clinical Trial Applications and Participation in Parent R01 and R21(Clinical Trial Required) Announcements | NIAMS | 10/06/2020 | |
| NOT-OD-20-170 | Reissue of Parent Research Supplements to Promote Diversity in Health-Related Research FOA in October 2020 | OD | 10/10/2020 | |
| Diversity Supplement | NIAMS | 1/1/2021 | |
| NOT-AR-21-014 | Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed) | NIAMS, NIAID, NIDCR, ORWH | 2/25/2021 | |
| NOT-AR-21-013 | Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogren’s Syndrome (UC2 Clinical Trial Optional) | NIAMS, NIAID, NIDCR, ORWH | 2/25/2021 | |
| NOT-OD-21-074 | Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows | NIH | 3/15/2021 | |
| NOT-AR-21-020 | Notice of NIAMS Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)" | NIH | 4/21/2021 | |
| NOT-GM-21-057 | Continuation of Temporary Extension of Applicant Eligibility in "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" Funding Opportunity Announcements | NIGMS | 8/17/2021 | |
| NOT-AR-22-015 | Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed) | NIAMS | 12/20/2021 | |
| NOT-OD-23-083 | Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Elucidate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional) | OBSSR, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIDA, NIGMS, NIMH, NINR, NIMHD, NCI | 3/8/2023 | 04/11/2023 |
| RFA-OD-23-013 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) | NIH, ORWH, NHLBI, NIA, NIAMS, NICHD, NCI | 3/9/2023 | 06/21/2024 |
| RFA-OD-23-014 | Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) | NIH, ORWH, NHLBI, NIA, NIAMS, NICHD, NCI | 3/8/2023 | 06/21/2024 |
| NOT-AR-23-018 | Notice of NIAMS Withdrawal from PA-20-194 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Required" | NIAMS | 5/8/2023 | |
| NOT-AR-23-019 | Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed" | NIAMS | 5/8/2023 | |
| NOT-AR-23-006 | Notice of Special Interest (NOSI): Supporting Exploratory/Developmental Research Focused on NIAMS Core Mission Areas | NIAMS | 4/27/2023 | 1/8/2027 |
| PA-23-189 | Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | NIH, CDC, NCI, NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, FIC, NCCIH, NCATS, SGMRO, ORIP, Common Fund, ODSS | 6/29/23 | 5/08/2026 |
| PA-23-231 | PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) | NIH, CDC | 8/05/2023 | 4/06/2024 |
| PA-23-230 | PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) | NIH, CDC, FDA | 8/07/2023 | 4/06/2024 |
| PAR-24-035 | Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | NIH, NIAMS | 11/06/2023 | 11/03/2026 |
| PAR-24-036 | Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | NIH, NIAMS | 11/06/2023 | 11/03/2026 |
| NOT-AR-24-006 | Notice of Intent to Publish HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional) | NIAMS, NICHD, OBSSR | 1/01/2024 | 11/10/2024 |
| NOT-AR-24-012 | Notice of NIAMS' Participation in PAR-24-053, "Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)" | NIAMS | 02/07/2024 | |
| NOT-NR-24-008 | Pre-Application Webinar for RFA-NR-24-005: Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 Clinical Trial Optional) | NINR, NIAMS, NIMH, NIMHD, SGMRO | 03/12/2024 | |
| NOT-OD-24-104 | Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2024 | NIH, AHRQ, HRSA | 04/23/2024 | |
| NOT-CA-24-045 | Notice of Preapplication Webinar for NOSI NOT-CA-24-033: Telehealth Research in Cancer Care | NCI | 04/25/2024 | |
| NOT-DA-24-016 | Phase-out and Termination of NIDA MERIT Awards for Established Investigators | NIDA | 04/23/2024 | |
| NOT-DA-24-017 | NIDA MERIT Awards for Early Stage Investigators (ESI) | NIDA | 04/23/2024 | |
| NOT-ES-24-007 | Request for Information (RFI) on the Use of In Vitro Lung Models in Inhalation Toxicology Research with Potential Application to Regulatory Decision-Making | NIEHS | 04/24/2024 | 06/07/2024 |
| NOT-AI-24-035 | Notice of Change to Key Date Section in PAR-24-080, “Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)” | NIAID, NIMHD | 04/25/2024 | 10/10/2025 |
| NOT-AI-24-046 | Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) | NIAID | 04/25/2024 | |
| NOT-DA-24-030 | Notice to Update PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" | NIDA | 04/25/2024 | |
| NOT-HD-24-024 | Notice of Correction to Key Dates for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)" | NICHD | 04/22/2024 | 01/08/2025 |
| NOT-MH-24-245 | Notice of Participation of NIMH in PAR-23-309 "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)" | NIMH | 04/24/2024 | |
| NOT-MH-24-250 | Notice of Clarification of NIMH Specific Areas of Research Interest in PAR-24-144 and PAR-24-145, "Support for Research Excellence (SuRE) and (SuRE-First) Awards (R16 - Clinical Trial Not Allowed) | 04/23/2024 | | |
| NOT-CA-24-040 | Notice of Special Interest: Administrative Supplements to Support Collection of Spanish Normative Data and Determination of Test-Retest Reliability Estimates of Neuropsychological Tests for NCI Clinical Trials | NCI | 04/22/2024 | 06/22/2024 |
| NOT-CA-24-044 | Notice of Special Interest (NOSI): Administrative Supplements for the Study of the Diverse Aspects of Uterine Serous Carcinoma (Clinical Trial Not Allowed) | NCI | 04/24/2024 | 07/02/2024 |
| PA-24-175 | Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-176 | Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | NIH | 04/24/2024 | 05/08/2024 |
| PA-24-177 | Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-181 | Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Required) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-182 | Mentored Clinical Scientist Research Career Development Award (Parent K08 – Independent Clinical Trial Not Allowed) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-183 | Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-187 | Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | NIH | 04/25/2024 | 05/08/2027 |
| PA-24-188 | Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) | NIH | 04/25/2024 | 05/08/2027 |
| PA-24-189 | Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) | NIH | 04/25/2024 | 05/08/2027 |
| PA-24-190 | Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) | NIH | 04/23/2024 | 05/08/2027 |
| PA-24-191 | Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | NIH | 04/23/2024 | 05/08/2027 |
| PA-24-192 | Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) | NIH | 04/23/2024 | 05/08/2027 |
| PA-24-193 | NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Required) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-194 | NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) | NIH | 04/24/2024 | 05/08/2027 |
| PA-24-195 | NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) | NIH | 04/24/2024 | 05/08/2027 |
| RFA-AG-25-004 | Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required) | NIH | 04/24/2024 | 10/11/2024 |
| RFA-AI-24-017 | Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) | NIH | 04/23/2024 | 08/21/2024 |
| RFA-AI-24-025 | Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) | NIH | 04/25/2024 | 10/10/2024 |
| RFA-CA-24-022 | SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | NIH | 04/23/2024 | 08/22/2024 |
| RFA-CA-24-023 | Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) | NIH | 04/23/2024 | 8/22/2024 |
| RFA-DK-25-010 | Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) | NIH | 04/23/2024 | 07/18/2024 |
| RFA-FD-24-040 | Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional | FDA | 04/23/2024 | 07/04/2024 |
| RFA-FD-24-041 | Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional | FDA | 04/23/2024 | 07/04/2024 |
| RFA-HD-25-009 | Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) | NIH | 04/25/2024 | 07/25/2024 |
| RFA-NR-24-006 | Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) | NIH | 04/25/2024 | 03/11/2025 |
| PAR-24-208 | NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | NIH | 6/02/24 | 3/05/2027 |
| PA-24-245 | PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) | NIH, CDC, FDA | 07/03/2024 | 04/06/2025 |
| PA-24-246 | PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) | NIH, CDC | 07/03/2024 | 04/06/2025 |
| PA-24-247 | PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) | NIH | 07/03/2024 | 04/06/2025 |
| PA-24-248 | PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) | NIH | 07/03/2024 | 04/06/2025 |
| PAR-24-225 | Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) | NIH | 08/07/2024 | 09/08/2027 |
| PAR-24-226 | Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) | NIH | 08/07/2024 | 09/08/2027 |
| RFA-AR-25-005 | HEAL Initiative: INTERACT INTEgRAtive Back Pain Longitudinal Cohort Teams (UC2 Clinical Trial Optional) | NIH | 09/11/2024 | 10/12/2024 |
| PAR-25-143 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | NIH | 10/31/2024 | 1/16/2025 |
| PAR-25-144 | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | NIH | 10/30/2024 | 1/5/2025 |